Naga Rajiv Lakkaniga

10PUBLICATIONS

11CO-AUTHORS

Predictive and prognostic markersMolecular targetsBiomolecular modelling and designTraditional Chinese medicine and treatmentsBiologically active molecules

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 26, 2026

TTK Overexpression as a Prognostic Indicator and Immune Modulator in Kidney Renal Clear Cell Carcinoma.

|Apr 17, 2026

Synergistic Combinations for Improved Therapeutic Outcomes in Triple Negative Breast Cancer.

|Dec 08, 2025

Evaluating the FEP+ protocol for predicting binding affinity of congeneric ligands towards various soluble proteins.

Shashi Kumar Sampangin Venkatesh, Arpan Das, Naga Rajiv Lakkaniga

|Nov 03, 2025

Network pharmacology based study of TCM formulations for non-insulin dependent diabetes mellitus.

Avani Jha, Shashi Kumar Sampangin Venkatesh, Naga Rajiv Lakkaniga

|Jun 06, 2025

Evolution of structure-guided drug design strategies targeting mutations in codon 12 of KRAS.

|Jan 09, 2025

Exploring the Conformational Space of MPS1 Kinase Using Metadynamics.

Anuradha Singh, Naga Rajiv Lakkaniga

Pageof 2

Frequent Collaborators

Hong-Yu Li

Francesca Carlomagno

Amrita Chatterjee

Monisha Jayaprakasan

Anirban Kr Chakrabarty

Dipankar Banerjee

Avinash Narwaria

Sunil Kumar Dubey

Parthasarathi Das

Navnath S Gavande

Frequent Collaborators

Hong-Yu Li

Francesca Carlomagno

Amrita Chatterjee

Monisha Jayaprakasan